Chinese expert consensus statement on metformin in clinical practice
Metformin, one of the most widely used oral hypoglycemic agents in the world, plays an important role in treating type 2 diabetes for decades, and it has been recommended as a first-line drug in diabetes guidelines around the world because of the good efficacy and safety for monotherapy and combinat...
Gespeichert in:
Veröffentlicht in: | Chinese medical journal 2020-06, Vol.133 (12), p.1445-1447 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Metformin, one of the most widely used oral hypoglycemic agents in the world, plays an important role in treating type 2 diabetes for decades, and it has been recommended as a first-line drug in diabetes guidelines around the world because of the good efficacy and safety for monotherapy and combination therapy, evidence of health economic benefits, and definite clinical evidence in the prevention of cardiovascular complications. [...]some clinicians and patients still have misunderstandings about the use of metformin, which makes some patients, that could formally benefit from metformin therapy miss treatment opportunities. [...]the Chinese Expert Consensus Statement on Metformin in Clinical Practice was jointly formed by endocrinologists and pharmaceutical experts with the aim of guiding clinicians and patients to correctly understand and rationally use Metformin (Supplementary file, http://links.lww.com/CM9/A237). Yi-Ming Mu1, Li-Nong Ji2, Guang Ning3, Guang-Wei Li4, Zhong-Yan Shan5, Yan Li6, Zi-Lin Sun7, Yan-Bing Li8, Jia-Jun Zhao9, Wei-Qing Wang2, Da-Long Zhu10, Tian-Pei Hong11, Nan-Wei Tong12, Zhi-Guang Zhou13, Da-Jin Zou14, Chao Liu15, Qiang Li16, Li-Xin Guo17, Yong-De Peng18, Lu-Lu Chen19, Xin-Hua Xiao20, Xue-Feng Yu21, You-Min Wang22, Qiu-He Ji23, Qi-Fu Li24, Chun-Lin Li25, Quan-Min Li26, Li-Xin Shi27, Yi-Ming Li28, Yong-Quan Shi29, Suo-Di Zhai30, Zhi-Gang Zhao31, Wan-Hua Yang32, Li-Wei Ji33, Rong-Sheng Zhao30, Jiu-Hong Wu34 1Department of Endocrinology, People's Liberation Army General Hospital, Beijing 100853, China 2Department of Endocrinology, Peking University People's Hospital, Beijing 100044, China 3Department of Endocrinology and Metabolism, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China 4Department of Endocrinology, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, China 5Department of Endocrinology, the First Hospital of China Medical University, Shenyang, Liaoning 110001, China 6Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China 7Department of Endocrinology, Zhongda Hospital Southeast University, Nanjing, Jiangsu 210009, China 8Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510000, China 9Department of Endocrinology, Shandong Provincial Hospital, Jinan, Shandong 250021, China 10Department of Endocrinology, Nanjing Drum Tow |
---|---|
ISSN: | 0366-6999 2542-5641 2542-5641 |
DOI: | 10.1097/CM9.0000000000000883 |